Briganix 90 Mg Tablets

Briganix 90 mg Tablets: Complete Patient & Clinical Guide

Briganix 90 mg is a specialized prescription medication used to treat a specific type of lung cancer known as non-small cell lung cancer (NSCLC). It is manufactured by Beacon Pharmaceuticals, a prominent pharmaceutical company known for producing high-quality oncology treatments.

The active ingredient in Briganix is Brigatinib. This medication belongs to an advanced class of targeted therapies that block the specific proteins responsible for tumor growth, offering a highly focused treatment option for eligible patients.

Critical Medical Disclaimer

Briganix 90 mg is a high-potency oncological medication. This guide is purely for informational purposes and must never replace direct medical advice from your oncologist or healthcare provider. Always follow your medical team’s exact dosing schedules and safety protocols.

What is Briganix 90 mg and How Does It Work?

Briganix is classified as a tyrosine kinase inhibitor (TKI). Specifically, it targets a genetic alteration known as Anaplastic Lymphoma Kinase (ALK).

In some patients with non-small cell lung cancer, the ALK gene abnormally fuses with another gene, creating an altered protein that signals cancer cells to grow and divide uncontrollably. According to the National Center for Biotechnology Information (NCBI), Brigatinib works by binding to and blocking this abnormal ALK protein. By shutting down these growth signals, the medication helps slow down or stop the spread of cancer cells, and can even shrink existing tumors.

• Targeted Efficacy: Unlike traditional chemotherapy, which impacts both healthy and unhealthy multiplying cells, targeted therapies like Briganix specifically seek out cells expressing the mutated ALK protein.

• Brain Penetration: Clinical profiles managed by Drugs.com highlight that Brigatinib is highly effective at crossing the blood-brain barrier, making it an essential treatment option for patients whose lung cancer has spread to the brain.

Product Quick Facts

How to Take Briganix 90 mg Tablets

Your oncologist will provide a very specific dosing plan, which frequently involves a gradual dose increase to help your body adjust to the medicine safely.

• Follow the Lead-In Protocol: Clinical protocols typically start patients on a “lead-in” dose of 90 mg once daily for the first 7 days. If the medication is tolerated well, your doctor will generally increase the dose to 180 mg once daily.

• Administration: Swallow the tablet whole with a full glass of water. Do not crush, chew, or break the tablet.

• Food Independence: You can take Briganix with or without meals. Maintain a consistent routine by taking it at the exact same time every day.

• Grapefruit Warning: Avoid eating grapefruit or drinking grapefruit juice while taking Briganix. Grapefruit can interfere with how your liver breaks down the drug, raising the medicine levels in your blood to unsafe amounts.

• Managing a Missed Dose: If you miss a dose or vomit after taking your tablet, skip that dose entirely. Take your next scheduled dose at your regular time the next day. Never take a double dose to make up for a missed one.

Potential Side Effects

Because targeted therapies affect systemic pathways, patients may experience various side effects. Always report any new or worsening symptoms to your oncology team immediately.

Common Side Effects

These reactions are frequently reported and can usually be managed with supportive care from your doctor:

• Nausea, diarrhea, or mild stomach pain

• Generalized fatigue or muscle weakness

• Headaches

• Coughing or mild shortness of breath

• Changes in taste or dry skin

Serious Side Effects Requiring Immediate Attention

Contact your medical care team right away if you notice signs of severe complications:

• Lung Problems (Interstitial Lung Disease): New or worsening breathing difficulties, chest pain, or fever, especially during the first week of treatment.

• High Blood Pressure (Hypertension): Severe headaches, dizziness, or blurred vision.

• Vision Changes: Double vision, flashes of light, or blurred vision.

• Muscle Damage: Unexplained muscle pain, tenderness, or weakness accompanied by dark-colored urine.

Critical Drug Interactions and Precautions

Before beginning your treatment with Briganix 90 mg, provide your doctor with a complete list of all medications, herbal supplements, and over-the-counter drugs you take.

• CYP3A Inhibitors and Inducers: Brigatinib is heavily processed by specific liver enzymes. Medications like certain antibiotics (ketoconazole, clarithromycin) or St. John’s Wort can dramatically alter how your body processes Briganix, causing it to become either ineffective or dangerously toxic.

• Pregnancy and Breastfeeding: Brigatinib can cause severe harm to an unborn baby. Both male and female patients should use highly effective birth control methods during treatment and for at least 4 months after the final dose. Do not breastfeed while taking this medication.

Frequently Asked Questions (FAQs)

How do I know if my lung cancer is ALK-positive?

Your healthcare team will perform a specialized genetic biopsy or blood test on your tumor tissue before prescribing Briganix. This test specifically checks for the presence of the abnormal ALK gene fusion.

What makes Briganix different from standard chemotherapy?

Traditional chemotherapy works by aggressively attacking all fast-growing cells in the body, which can cause widespread side effects like severe hair loss. Briganix is a targeted oral therapy designed to block the specific mutated proteins inside cancer cells, leaving most healthy cells alone.

How should I store the tablets?

Keep the tablets in their original bottle to protect them from moisture. Store the container at room temperature below 30°C (86°F) and keep it completely out of the reach of children and pets.

References

• For Active Ingredient & Mechanism Details (Brigatinib):

  National Center for Biotechnology Information (NCBI). (n.d.). PubChem Compound Summary for CID 68165247: Brigatinib. PubChem Database. https://pubchem.ncbi.nlm.nih.gov/compound/Brigatinib

• For Dosing, Lead-In Protocols, and Side Effects:

  Mayo Clinic. (n.d.). Brigatinib (Oral Route) Standard Cancer Treatment Guidelines & Dosing Protocols. Mayo Clinic Drug Reference Guide. https://www.mayoclinic.org/drugs-supplements/brigatinib-oral-route/description/drg-20406249

• For Drug Interaction & Patient Encyclopedia Files:

  Kaiser Permanente. (n.d.). Brigatinib 90 mg Oral Tablet Clinical Encyclopedia. Kaiser Permanente Health & Wellness Database. https://healthy.kaiserpermanente.org/health-wellness/drug-encyclopedia

• For Official Manufacturer Data:

  Beacon Pharmaceuticals PLC. (n.d.). Global Product Portfolio: Briganix (Brigatinib). Beacon Oncology Division. https://global.beaconpharma.com.bd/product/briganix